SpineGuard S.A. (ALSGD.PA)
SpineGuard S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Vincennes, IF, FR. The stock last traded at $0.09, down 0.57% on the session, giving a market capitalisation of $8.5M. Its beta of 0.58 implies it has historically moved less than the broad market.
SpineGuard S.A. specializes in the global design, development, and commercialization of advanced medical instruments for surgical procedures. Their product line includes various PediGuard probes: the Straight probe for precise screw placement; the Curved probe, featuring a tapered tip to facilitate easier pedicle penetration; and the Cannulated probe, engineered to help surgeons minimize radiation exposure during minimally-invasive operations. They also offer the PediGuard Threaded Device, a specialized drilling tool. Complementing these devices, SpineGuard provides the DSG (Dynamic Surgical Guidance) Connect app, which collects and visualizes real-time signals from DSG-enabled instruments during pedicle drilling, alongside the DSG smart screw for streamlined one-step screw insertion. SpineGuard's innovative solutions serve a broad spectrum of healthcare stakeholders, including patients, surgeons, operating room staff, and other healthcare providers. Founded in 2009, the company is headquartered in Vincennes, France.
SpineGuard S.A. is most often compared with the following Healthcare names: